Adicet Bio, Inc. SEC filings ACET

Adicet Bio, Inc. has 680 filings in SEC EDGAR's recent list, going back to Oct 27, 2017. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 26.

Adicet Bio, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Sep 28, 2026 Sep 28, 2026
8-K Current report
Regulation FD disclosure
Sep 8, 2026 Sep 8, 2026
8-K Current report
Regulation FD disclosure
Sep 1, 2026 Sep 1, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
10-K/A Amended annual report May 20, 2026 Dec 31, 2025
S-8 POS Filing May 13, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Apr 29, 2026
8-K Current report
Unregistered share sale
Apr 28, 2026 Apr 27, 2026
EFFECT Filing Mar 23, 2026 —
CORRESP Letter to the SEC Mar 19, 2026 —
UPLOAD Letter from the SEC Mar 18, 2026 —
S-8 Employee stock plan registration Mar 12, 2026 —
S-3 Shelf registration Mar 12, 2026 —
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2026 Jan 7, 2026
8-K Current report
Bylaw or fiscal year change, Other events
Dec 29, 2025 Dec 26, 2025
8-K Current report
Shareholder vote results
Dec 19, 2025 Dec 19, 2025
DEF 14A Proxy statement Nov 17, 2025 Dec 19, 2025
PRE 14A Preliminary proxy statement Nov 5, 2025 Dec 19, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Listing notice
Oct 7, 2025 Oct 7, 2025
8-K Current report
Material agreement
Oct 7, 2025 Oct 7, 2025
424B5 Prospectus supplement Oct 7, 2025 —
8-K Current report
Other events
Oct 7, 2025 Oct 7, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
S-8 Employee stock plan registration Jul 25, 2025 —
8-K Current report
Exit or restructuring costs, Other events
Jul 23, 2025 Jul 22, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 11, 2025
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Apr 29, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 17, 2025 Apr 14, 2025
8-K Current report
Listing notice
Apr 11, 2025 Apr 7, 2025
S-8 POS Filing Mar 26, 2025 —
424B5 Prospectus supplement Mar 18, 2025 —
EFFECT Filing Mar 14, 2025 —
CORRESP Letter to the SEC Mar 12, 2025 —
UPLOAD Letter from the SEC Mar 11, 2025 —
S-8 Employee stock plan registration Mar 6, 2025 —
S-3 Shelf registration Mar 6, 2025 —
10-K Annual report Mar 6, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
8-K Current report
Other events
Feb 5, 2025 Feb 5, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 19, 2024 Dec 19, 2024
8-K Current report
Agreement ended
Nov 27, 2024 Nov 27, 2024
8-K Current report
Regulation FD disclosure, Other events
Nov 18, 2024 Nov 18, 2024
8-K Current report
Material agreement
Nov 15, 2024 Nov 8, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 16, 2024 Oct 16, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 30, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 19, 2024 Sep 19, 2024
8-K Current report
Other events
Sep 10, 2024 Sep 10, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 19, 2024 Aug 15, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Regulation FD disclosure
Jul 8, 2024 Jul 8, 2024
8-K Current report
Regulation FD disclosure, Other events
Jun 24, 2024 Jun 24, 2024
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 7, 2024 Jun 5, 2024
8-K Current report
Regulation FD disclosure
Jun 5, 2024 Jun 5, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
8-K Current report
Regulation FD disclosure
May 10, 2024 May 10, 2024
DEFR14A Filing Apr 26, 2024 —
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 23, 2024 —
DEF 14A Proxy statement Apr 23, 2024 Apr 23, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 22, 2024 Apr 22, 2024
PRE 14A Preliminary proxy statement Apr 12, 2024 Apr 12, 2024
8-K Current report
Material agreement
Mar 22, 2024 Mar 22, 2024
424B5 Prospectus supplement Mar 22, 2024 —
S-8 POS Filing Mar 19, 2024 —
S-8 Employee stock plan registration Mar 19, 2024 —
10-K Annual report Mar 19, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 19, 2024 Mar 19, 2024
8-K Current report
Material agreement, Results of operations, Other events
Jan 24, 2024 Jan 22, 2024
424B5 Prospectus supplement Jan 24, 2024 —
424B5 Prospectus supplement Jan 22, 2024 —
8-K Current report
Regulation FD disclosure
Jan 16, 2024 Jan 16, 2024
8-K Current report
Regulation FD disclosure, Other events
Jan 4, 2024 Jan 4, 2024
8-K Current report
Officer or director change
Nov 13, 2023 Nov 7, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
S-8 POS Filing Aug 9, 2023 —
S-8 Employee stock plan registration Aug 9, 2023 —
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 11, 2023 Jul 10, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 26, 2023 Jun 26, 2023
8-K Current report
Material agreement
Jun 5, 2023 May 30, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2023 Jun 1, 2023
8-K Current report
Regulation FD disclosure, Other events
May 18, 2023 May 18, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
ARS Annual report to shareholders Apr 18, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 18, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 18, 2023 —
S-8 Employee stock plan registration Mar 15, 2023 —
10-K Annual report Mar 15, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 15, 2023 Mar 15, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
8-K Current report
Regulation FD disclosure, Other events
Dec 12, 2022 Dec 10, 2022
8-K Current report
Material agreement
Dec 8, 2022 Dec 2, 2022
8-K Current report
Regulation FD disclosure
Nov 10, 2022 Nov 10, 2022
424B5 Prospectus supplement Nov 8, 2022 —
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Regulation FD disclosure, Other events
Nov 3, 2022 Nov 3, 2022
8-K Current report
Other events
Oct 5, 2022 Oct 5, 2022
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 10, 2022 Aug 10, 2022
8-K Current report
Material agreement
Jun 21, 2022 Jun 16, 2022
8-K Current report
Regulation FD disclosure, Other events
Jun 6, 2022 Jun 6, 2022
8-K Current report
Shareholder vote results
Jun 3, 2022 Jun 2, 2022
8-K Current report
Regulation FD disclosure, Other events
May 26, 2022 May 26, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 12, 2022 May 12, 2022
EFFECT Filing May 9, 2022 —
CORRESP Letter to the SEC May 5, 2022 —
8-K Current report
Regulation FD disclosure
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 21, 2022 —
DEF 14A Proxy statement Apr 21, 2022 Jun 2, 2022
8-K Current report
Regulation FD disclosure
Apr 19, 2022 Apr 19, 2022
8-K Current report
Material agreement
Mar 24, 2022 Mar 18, 2022
UPLOAD Letter from the SEC Mar 16, 2022 —
S-3/A Filing Mar 16, 2022 —
S-8 Employee stock plan registration Mar 16, 2022 —
S-3 Shelf registration Mar 15, 2022 —
10-K Annual report Mar 15, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 15, 2022 Mar 15, 2022
8-K Current report
Other events
Feb 3, 2022 Jan 28, 2022
8-K Current report
Material agreement, Other events
Dec 10, 2021 Dec 7, 2021
424B5 Prospectus supplement Dec 9, 2021 —
424B5 Prospectus supplement Dec 7, 2021 —
8-K Current report
Other events
Dec 6, 2021 Dec 6, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 18, 2021 Nov 17, 2021
8-K Current report
Regulation FD disclosure, Other events
Nov 12, 2021 Nov 12, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
8-K Current report
Agreement ended
Oct 29, 2021 Oct 27, 2021
8-K Current report
Material agreement
Oct 25, 2021 Oct 19, 2021
8-K Current report
Regulation FD disclosure, Other events
Sep 13, 2021 Sep 13, 2021
10-K/A Amended annual report Aug 16, 2021 Dec 31, 2020
S-8 Employee stock plan registration Aug 12, 2021 —
10-Q Quarterly report Aug 12, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 12, 2021 Aug 12, 2021
8-K Current report
Agreement ended
Jul 30, 2021 Jul 29, 2021
8-K Current report
Material agreement
Jul 23, 2021 Jul 19, 2021
8-K Current report
Material agreement
Jul 1, 2021 Jun 25, 2021
EFFECT Filing May 21, 2021 —
424B3 Prospectus May 21, 2021 —
CORRESP Letter to the SEC May 19, 2021 —
UPLOAD Letter from the SEC May 18, 2021 —
8-K/A Amended current report
Results of operations, Officer or director change
May 17, 2021 May 11, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Results of operations, Officer or director change
May 17, 2021 May 11, 2021
S-3 Shelf registration May 13, 2021 —
8-K Current report
Shareholder vote results
Apr 29, 2021 Apr 27, 2021
8-K Current report
Material agreement
Apr 9, 2021 Apr 7, 2021
EFFECT Filing Mar 30, 2021 —
CORRESP Letter to the SEC Mar 26, 2021 —
DEFA14A Additional proxy material Mar 18, 2021 —
DEF 14A Proxy statement Mar 18, 2021 Apr 27, 2021
UPLOAD Letter from the SEC Mar 18, 2021 —
S-3 Shelf registration Mar 12, 2021 —
S-8 Employee stock plan registration Mar 12, 2021 —
10-K Annual report Mar 12, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 11, 2021 Mar 11, 2021
8-K Current report
Other events
Mar 10, 2021 Mar 10, 2021
8-K Current report
Officer or director change
Mar 4, 2021 Mar 2, 2021
8-K Current report
Officer or director change
Feb 19, 2021 Feb 16, 2021
8-K Current report
Material agreement, Other events
Feb 16, 2021 Feb 10, 2021
424B5 Prospectus supplement Feb 11, 2021 —
S-3MEF Filing Feb 10, 2021 —
424B5 Prospectus supplement Feb 10, 2021 —
8-K Current report
Agreement ended
Feb 9, 2021 Feb 7, 2021
S-8 POS Filing Jan 28, 2021 —
S-8 POS Filing Jan 28, 2021 —
8-K Current report
Material agreement
Jan 5, 2021 Dec 30, 2020
424B5 Prospectus supplement Dec 1, 2020 —
8-K Current report
Material agreement, Agreement ended
Dec 1, 2020 Nov 30, 2020
8-K Current report
Officer or director change
Dec 1, 2020 Nov 24, 2020
S-8 Employee stock plan registration Nov 12, 2020 —
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Officer or director change
Oct 26, 2020 Oct 26, 2020
8-K Current report
Other events
Oct 22, 2020 Oct 22, 2020
8-K Current report
Officer or director change
Oct 8, 2020 Oct 4, 2020
S-8 Employee stock plan registration Oct 2, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ACET (Nasdaq)
Fiscal year ends
December 26
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1720580
Former names
resTORbio, Inc. (until Aug 21, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.